Stock screenerAll disclosures →
EDGAR →
IOVA
SetupConviction 80LongHealthcareScan · Tue, Sep 8, 2026High tight flagmomentum
IOVA$8.71-0.91%
ResistanceSupportVol 14Vol MA14 14.98M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest -76.92%· 3 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Trade plan
LongReward : Risk0.92Entry
Entry
9.36
Risk
Stop
7.85
-16.2% to stop
Reward
Target 1
10.75
+14.8% to target
Stretch
Target 2
12.14
+29.7% to T2
Risk : reward balance
Risk to stopReward to target
Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.
Price8.71
Change-0.91%
Gap-1.42%
Rel volume0.46×
Avg volume14.6M
Avg $ vol116.63M
SMA 207.91
SMA 505.99
SMA 2003.96
Price vs 50+45.47%
Price vs 200+119.97%
MA stackbullish
50/200 cross—
Supertrendup · 7.30
RSI (14)68
MACD hist-0.03
MACD crossbear · 4d
Stoch %K / %D70 / 74
ADX (14)52
+DI / −DI35 / 11
RSI divergence—
MACD divergence—
ATR %+5.71%
ADR %6.61%
52w high8.99
52w low1.81
From 52w high-3.11%
Above 52w low+381.22%
New 52w highNo
SqueezeOff
Bollinger width39.39%
%B0.76
Donchian pos79.56%
Donchian high9.36
Donchian low6.18
AVWAP (52w high)8.47
vs AVWAP high+2.78%
AVWAP (52w low)4.03
vs AVWAP low+116.35%
OBV trendUp
Chaikin MF (20)0.29
Today vs 20d0.46×
Avg vol (14d)14.98M
Avg vol (20d)14.6M
Avg $ vol (20d)116.63M
Market cap3.95B
RS 3m (vs SPY)+103.38%
RS 6m (vs SPY)+56.80%
RS line new highNo
Trend template8/8
Technical rank94.8
1 week+6.61%
1 month+37.38%
3 months+117.75%
6 months+61.00%
1 year+249.80%
YTD+245.63%
P/E-10.09
P/B5.36
P/S14.97
P/FCF-11.73
EPS-1.09
Div yield—
ROE-53.12%
ROA-42.71%
Debt/Eq—
Current4.34
EV/EBITDA-9.82
Gross margin—
Net margin-148.38%
Rev growth60.60%
EPS growth-5.05%
Price target9.14
Target upside4.94%
Analyst ratingBuy
Institutional69.95%
Ent. value3.83B
Revenue99.31M
Net income-47.31M
Gross profit—
Free cash flow-336.24M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out446.5M
Employees975
ListedWed, May 26, 2010
Free float372.08M
Float %90.3%
Short interest102.94M
Days to cover4.8d
Short volume43.7%
Squeeze score66 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.11 vs −$0.17
Last surprise+35.3% beat
Setup gradeA
Conviction80 / 100
Pattern quality78%
Tech rank94.8 / 100
Group rank96 / 100 · Leading
Status laneSetting up
Setup directionLong
Pattern familyMomentum
Resistance9.36
Support7.97
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- IONS Secures FDA Nod for Rare Brain Disorder Drug ZanvastroYahoo Finance · Fri, Sep 4, 2026
- Iovance Biotherapeutics to Present at Upcoming ConferencesYahoo Finance · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in IOVA
No recent disclosed trades by Congress in IOVA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IOVA · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kirby Daniel Gordon Chief Commercial Officer · Common Stock · 2026-08-10 | Exercise | 10K | — | 2026-08-10 | 2026-08-12 |
Kirby Daniel Gordon Chief Commercial Officer · Common Stock · 2026-08-10 | Tax | 2.44K | $16K | 2026-08-10 | 2026-08-12 |
Kirby Daniel Gordon Chief Commercial Officer · Restricted Stock Units · 2026-08-10 | Exercise | 10K | — | 2026-08-10 | 2026-08-12 |
Roche Corleen M. Chief Financial Officer · Common Stock · 2026-08-06 | Exercise | 49.99K | — | 2026-08-06 | 2026-08-10 |
Roche Corleen M. Chief Financial Officer · Common Stock · 2026-08-06 | Tax | 21.24K | $132K | 2026-08-06 | 2026-08-10 |
Roche Corleen M. Chief Financial Officer · Restricted Stock Units · 2026-08-06 | Exercise | 49.99K | — | 2026-08-06 | 2026-08-10 |
Countouriotis Athena Director · Deferred Restricted Stock Unit · 2026-06-16 | Grant | 90.32K | — | 2026-06-16 | 2026-06-18 |
Dukes Iain D. Director · Deferred Restricted Stock Unit · 2026-06-16 | Grant | 180.63K | — | 2026-06-16 | 2026-06-18 |
Puri Raj K. Chief Regulatory Officer · Restricted Stock Units · 2026-06-16 | Grant | 15K | — | 2026-06-16 | 2026-06-18 |
Maynard Ryan D Director · Deferred Restricted Stock Unit · 2026-06-16 | Grant | 90.32K | — | 2026-06-16 | 2026-06-18 |
SEC filings
EDGAR filings in IOVA · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.